Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma

Trial Profile

Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs B cell lymphoma vaccine (Primary)
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Sponsors XEME Biopharma
  • Most Recent Events

    • 30 Jun 2017 Last checked against ClinicalTrials.gov record.
    • 26 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Jun 2020.
    • 26 Jun 2017 Planned primary completion date changed from 1 Jul 2018 to 1 May 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top